✦ LIBER ✦

Evaluating Donor Lymphocyte Infusions (DLI) for the Treatment of Falling Chimerism, Minimal Residual Disease and Relapse After Pediatric Hematopoietic Stem Cell Transplantation (HSCT)

✍ Scribed by El-Bietar, Javier Amin; Martinez, Caridad; Bollard, Catherine M.; Naik, Swati; Leung, Kathryn; Gottschalk, Stephen; Ahmed, Nabil; Allen, Carl; Heslop, Helen E.; Brenner, Malcolm K.; Krance, Robert A.

Book ID: 122420091
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 74 KB
Volume: 19
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2012.11.207

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Outcome and long-term follow-up of allor

Outcome and long-term follow-up of alloreactive donor lymphocyte infusions given for relapse after myeloablative allogeneic hematopoietic stem cell transplantations (HSCT)

✍ Michallet, A S; Nicolini, F; Fürst, S; Le, Q H; Dubois, V; Hayette, S; Bourgeot, 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 346 KB

Modified Donor Lymphocyte Infusion (DLI)

Modified Donor Lymphocyte Infusion (DLI) for the Prophylaxis of Leukemia Relapse after Hematopoietic Stem Cell Transplantation in Patients with Advanced Leukemia—Feasibility and Safety Study

✍ Xiao-Jun Huang; Yu Wang; Dai-Hong Liu; Lan-Ping Xu; Huan Chen; Yu-Hong Chen; Wei 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 145 KB

The value of monitoring minimal residual

The value of monitoring minimal residual disease in the patients with donor lymphocyte infusion as intervention of relapsed/refractory acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation

✍ Xiao Ma; Depei Wu; Aining Sun; Huiying Qiu; Zhenzhen Fu; Xiaojin Wu; Suning Chen 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 389 KB 👁 2 views

Donor Lymphocyte Infusion for the Treatm

Donor Lymphocyte Infusion for the Treatment of Relapsed Acute Myeloid Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Analysis by the Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation

✍ Takami, Akiyoshi; Yano, Shingo; Yokoyama, Hiroki; Kuwatsuka, Yachiyo; Yamaguchi, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 341 KB

Short-Term Immunosuppressive Agents for

Short-Term Immunosuppressive Agents for Graft-Versus-Host Disease (GVHD) Prophylaxis After Donor Lymphocyte Infusion (DLI) Have No Influence on Graft-Versus-Leukemia (GVL) Effects and Could Improve Leukemia-Free Survival in Haploidentical Hematopoietic Stem Cell Transplantation (HSCT)

✍ C. Yan; D. Liu; L. Xu; H. Chen; W. Han; Y. Wang; K. Liu; X. Huang 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Combining Azacitidine (Vidaza®, Aza) and

Combining Azacitidine (Vidaza®, Aza) and Donor Lymphocyte Infusions (DLI) as First Salvage Treatment in Patients (PTS) With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS) Relapsing After Allogeneic Hematopoietic Stem Cell Transplantation (allo-SCT): Interim-Analysis From the Azarela-Trial (NCT-00795548)

✍ T. Schroeder; A.G. Czibere; N. Kröger; U. Platzbecker; G. Bug; L. Uharek; T. Luf 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 63 KB